DK1446131T3 - Anvendelse af specifik dosis af fondaparinux-natrium til behandling af ACS - Google Patents

Anvendelse af specifik dosis af fondaparinux-natrium til behandling af ACS

Info

Publication number
DK1446131T3
DK1446131T3 DK02787601T DK02787601T DK1446131T3 DK 1446131 T3 DK1446131 T3 DK 1446131T3 DK 02787601 T DK02787601 T DK 02787601T DK 02787601 T DK02787601 T DK 02787601T DK 1446131 T3 DK1446131 T3 DK 1446131T3
Authority
DK
Denmark
Prior art keywords
acs
treatment
specific dose
fondaparinux sodium
fondaparinux
Prior art date
Application number
DK02787601T
Other languages
Danish (da)
English (en)
Inventor
Anthonie Wilhelmus A Lensing
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8181220&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1446131(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DK1446131T3 publication Critical patent/DK1446131T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024Esters of saccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK02787601T 2001-11-13 2002-11-07 Anvendelse af specifik dosis af fondaparinux-natrium til behandling af ACS DK1446131T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01204323 2001-11-13
PCT/EP2002/012482 WO2003041722A1 (en) 2001-11-13 2002-11-07 Use of specific dose of fondaparinux sodium for the treatment of acs

Publications (1)

Publication Number Publication Date
DK1446131T3 true DK1446131T3 (da) 2007-09-10

Family

ID=8181220

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02787601T DK1446131T3 (da) 2001-11-13 2002-11-07 Anvendelse af specifik dosis af fondaparinux-natrium til behandling af ACS

Country Status (37)

Country Link
US (1) US20040248848A1 (pl)
EP (1) EP1446131B1 (pl)
JP (1) JP4523276B2 (pl)
KR (1) KR20050044318A (pl)
CN (1) CN1602197A (pl)
AP (1) AP1820A (pl)
AR (1) AR037291A1 (pl)
AT (1) ATE361753T1 (pl)
AU (1) AU2002351915B2 (pl)
BR (1) BR0212915A (pl)
CA (1) CA2465776A1 (pl)
CO (1) CO5580790A2 (pl)
CY (1) CY1106765T1 (pl)
DE (1) DE60220084T2 (pl)
DK (1) DK1446131T3 (pl)
EA (1) EA007325B1 (pl)
EC (1) ECSP045041A (pl)
ES (1) ES2287343T3 (pl)
GE (1) GEP20074097B (pl)
HK (1) HK1070561A1 (pl)
HR (1) HRP20040303B1 (pl)
HU (1) HU228959B1 (pl)
IL (2) IL161114A0 (pl)
IS (1) IS2484B (pl)
MA (1) MA27071A1 (pl)
ME (2) MEP1108A (pl)
MX (1) MXPA04003045A (pl)
NO (1) NO20041320L (pl)
NZ (1) NZ552129A (pl)
PE (1) PE20030740A1 (pl)
PL (1) PL206008B1 (pl)
PT (1) PT1446131E (pl)
RS (1) RS50906B (pl)
SI (1) SI1446131T1 (pl)
UA (1) UA80399C2 (pl)
WO (1) WO2003041722A1 (pl)
ZA (1) ZA200402464B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090075910A1 (en) * 2007-09-13 2009-03-19 Protia, Llc Deuterium-enriched fondaparinux
EP3271405A1 (en) * 2015-03-20 2018-01-24 Aarhus Universitet Inhibitors of pcsk9 for treatment of lipoprotein metabolism disorders
US10688249B2 (en) * 2015-06-11 2020-06-23 Virchow Biotech Pvt. Ltd. Multiple dose pharmaceutical compositions containing heparin and/or heparin-like compounds and devices and methods for delivering the same
CN107595769A (zh) * 2017-10-23 2018-01-19 上海博悦生物科技有限公司 一种磺达肝癸钠注射液组合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662442A1 (fr) * 1990-05-23 1991-11-29 Midy Spa Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant.
CA2199642C (en) * 1997-03-10 2001-05-08 Roger Cariou Compositions containing an association of aspirin and an anti-xa oligosaccharide and use of an anti-xa oligosaccharide optionally in combination with aspirin
FR2764511B1 (fr) * 1997-06-13 2000-09-08 Sanofi Sa Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire
AU2003225182B2 (en) * 2002-04-25 2009-02-26 Momenta Pharmaceuticals, Inc. Methods and products for mucosal delivery

Also Published As

Publication number Publication date
DE60220084D1 (de) 2007-06-21
EP1446131A1 (en) 2004-08-18
HRP20040303A2 (en) 2004-10-31
NZ552129A (en) 2008-04-30
MEP1108A (en) 2011-02-10
ZA200402464B (en) 2005-06-29
JP2005509007A (ja) 2005-04-07
EA200400382A1 (ru) 2004-10-28
DE60220084T2 (de) 2008-01-10
CO5580790A2 (es) 2005-11-30
AP2004003014A0 (en) 2004-06-30
CA2465776A1 (en) 2003-05-22
ME00229B (me) 2011-10-10
IL161114A0 (en) 2004-08-31
US20040248848A1 (en) 2004-12-09
KR20050044318A (ko) 2005-05-12
JP4523276B2 (ja) 2010-08-11
EP1446131B1 (en) 2007-05-09
ECSP045041A (es) 2004-04-28
HRP20040303B1 (en) 2012-02-29
MXPA04003045A (es) 2005-06-20
RS26704A (en) 2007-02-05
PL369027A1 (pl) 2005-04-18
IL161114A (en) 2010-11-30
PL206008B1 (pl) 2010-06-30
AP1820A (en) 2008-01-11
IS2484B (is) 2008-12-15
MA27071A1 (fr) 2004-12-20
EA007325B1 (ru) 2006-08-25
AR037291A1 (es) 2004-11-03
CY1106765T1 (el) 2012-05-23
GEP20074097B (en) 2007-05-10
PE20030740A1 (es) 2003-08-28
ES2287343T3 (es) 2007-12-16
UA80399C2 (en) 2007-09-25
RS50906B (sr) 2010-08-31
ATE361753T1 (de) 2007-06-15
HUP0401462A3 (en) 2006-04-28
HK1070561A1 (en) 2005-06-24
AU2002351915B2 (en) 2007-11-29
BR0212915A (pt) 2004-10-13
HUP0401462A2 (en) 2006-02-28
PT1446131E (pt) 2007-08-07
NO20041320L (no) 2004-06-14
WO2003041722A1 (en) 2003-05-22
SI1446131T1 (sl) 2007-10-31
HU228959B1 (en) 2013-07-29
IS7199A (is) 2004-03-29
CN1602197A (zh) 2005-03-30

Similar Documents

Publication Publication Date Title
DK1803718T3 (da) 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
DK1425001T3 (da) Phenethanolaminderivater til behandling af respiratoriske sygdomme
DK1446012T3 (da) Bakteriolytisk kombinationsterapi til behandling af tumorer
IS7691A (is) Lyfjasamsetningar til að meðhöndla æxli
DK1196163T3 (da) Farmaceutiske sammensætninger til behandling af insulinresistens
NO20033203D0 (no) Terapeutiske heterocykliske forbindelser
DK1259512T3 (da) Pteridinforbindelser til behandling af psoreasis
DK1282616T3 (da) Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter
DK1499730T3 (da) Immunokonjugater til behandling af tumorer
NO20033205L (no) Terapeutiske kromanforbindelser
DK1764111T3 (da) Vaginalt indgivne anti-dysrytmi midler til behandling af uterin dysrytmi
DK1176964T3 (da) Brug af ET743 til behandling af cancer
DE10158785B8 (de) Medizinisches Implantat
DK1596870T4 (da) Højdosis-ibandronatformulering
DK1443938T3 (da) Dosisenhed omfattende en prostaglantinanalog til behandling af forstoppelse
DE60222664D1 (de) Hautbehandlungsmittel
DK1434588T3 (da) 2-(amino-3,4-dioxo-1cyclobuten-1-yl)aminoalkylsyrederivater til behandling af smerte
DK1496918T3 (da) Anvendelse af natriummetaarsenit til behandling af tumorer
DK1446131T3 (da) Anvendelse af specifik dosis af fondaparinux-natrium til behandling af ACS
DK1351697T3 (da) Lægemiddel til fremme af regenerationen af væv
DK1224181T3 (da) Substituerede pyrroler som antiproliferative midler til behandling af cancer
NO20022253L (no) Middel til behandling av hepatitt C
DK1408977T3 (da) Kombinationsterapi for behandling af hjerteinsuffciens
FR2819396B1 (fr) Chevillere orthopedique perfectionnee
DK1286986T3 (da) Quinolinylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerte